Success Stories: Thanks to Our Case Preparation, NIW Win Made Possible for a South Korean Postdoctoral Research Fellow Working in Genetics

 

Client’s Testimonial:

“It has been such a pleasure to work with the team.”


On May 27th, 2022, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Research Fellow in the Field of Genetics (Approval Notice).


General Field: Genetics

Position at the Time of Case Filing: Postdoctoral Research Fellow

Country of Origin: South Korea

State of Residence at the Time of Filing: California

Approval Notice Date: May 27th, 2022

Processing Time: 9 months, 3 days


Case Summary:

The following is the list of evidence we collected for an expert in the field of genetics who asked our help for her NIW(National Interest Waiver) approval:

  • Her proposed endeavor was to continue applying single-cell computational tools to characterize the role of sensory neurons and glial cells in the airway and immune responses in order to better understand the transcriptional and molecular pathways required for normal lung function. Among other applications, her research is relevant to improving the treatment of respiratory diseases and alleviating the associated burden on society.
  • Her research advancing her proposed endeavor is of great importance because it expands the opportunities for sensory neurons and glial cells in the lungs to serve as therapeutic targets in the treatment of chronic diseases afflicting the airway and lungs. According to information from the Forum of International Respiratory Societies, respiratory diseases are the leading causes of death and disability around the world. It is obvious that the client’s breakthrough in characterizing the role of sensory neurons and glial cells in the airway is a significant contribution to her field and key advancement for the improved treatment of disease.
  • Her proposed endeavor also has broad implications for the United States, since respiratory diseases at large constitute a significant burden on U.S. schools, workplaces, neighborhoods, and states.
  • Due to its evident national importance, her research has in fact been supported with funding from the National Institutes of Health (NIH) through the National Institute of Child Health and Human Development (NICHD) and the National Institute of Mental Health (NIMH).
  • Her research has also resulted in 5 peer-reviewed journal articles (3 of them first-authored) which have been cited a total of 87 times according to Google Scholar, thereby demonstrating that these publications are widely recognized and relied upon in the field of genetics.
  • She has been pursuing research directly related to her proposed endeavor for 7 years now giving her authority over the area.
  • Finally, she also received 4 letters of recommendation from other experts who knew her work and supported it through their testimonials.

So, when her approval came through, we were very happy to have been a part of the success story. We wish her all the best in her future endeavors and look forward to further collaborations with her.


North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.


approval_table_2017

Approval Notices: https://www.wegreened.com/eb1_niw_approvals

Success Stories: https://www.wegreened.com/blog/

Website: www.wegreened.com

Free evaluation: https://www.wegreened.com/Free-Evaluation

Tel: 888.666.0969 (Toll Free)


To see more clients’ testimonials and approvals, please refer to:

Client's Testimonials

Approval Notices

To Learn More About Your Options CLICK HERE


Copyright © North America Immigration Law GroupWeGreened.com, All Rights Reserved.